A Phase 2A study of the Histone-Deacetylase Inhibitor ITF2357 in Patients with Jak2V617F Positive Chronic Myeloproliferative Neoplasms

被引：0

作者：

Rambaldi, Alessandro ^{[1
]}

Dellacasa, Chiara Maria ^{[2
]}

Salmoiraghi, Silvia ^{[2
]}

Spinelli, Orietta ^{[2
]}

Ferrari, Maria Luisa ^{[2
]}

Gattoni, Elisabetta ^{[3
]}

Guglielmelli, Paola ^{[4
]}

Vannucchi, Alessandro M. ^{[4
]}

Barosi, Giovanni ^{[5
]}

Barbui, Tiziano ^{[2
]}

机构：

[1] Hosp Santa Creu & Sant Pau, Clin Hematol Div, Barcelona, Spain

[2] Osped Riuniti Bergamo, USC Hematol, I-24100 Bergamo, Italy

[3] Policlin San Matteo, Fdn IRCCS, Lab Epidemiol Clin, I-27100 Pavia, Italy

[4] Univ Florence, Florence, Italy

[5] Ist Policlin San Matteo, Clin Epidemiol Unit, Ctr Study Myelofibrosis, Pavia, Italy

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：44 / 45

页数：2

共 50 条

[1] A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms
Rambaldi, Alessandro
Dellacasa, Chiara Maria
Finazzi, Guido
Carobbio, Alessandra
Ferrari, Maria Luisa
Guglielmelli, Paola
Gattoni, Elisabetta
Salmoiraghi, Silvia
Finazzi, Maria Chiara
Di Tollo, Silvia
D'Urzo, Carmine
Vannucchi, Alessandro M.
Barosi, Giovanni
Barbui, Tiziano
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (04) : 446 - 455
[2] The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2V617F
V Guerini
V Barbui
O Spinelli
A Salvi
C Dellacasa
A Carobbio
M Introna
T Barbui
J Golay
A Rambaldi
Leukemia, 2008, 22 : 740 - 747
[3] The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2V617F
Guerini, V.
Barbui, V.
Spinelli, O.
Salvi, A.
Dellacasa, C.
Carobbio, A.
Introna, M.
Barbui, T.
Golay, J.
Rambaldi, A.
LEUKEMIA, 2008, 22 (04) : 740 - 747
[4] Selective targeting of the JAK2V617F mutation in polycythemia vera and essential thrombocythemia by ITF2357, a novel histone deacetylase inhibitor
Guerini, Vittoria
Barbui, Valentina
Spinelli, Orietta
Salvi, Anna
Dellacasa, Chiara
Introna, Martino
Barbui, Tiziano
Golay, Josee
Rambaldi, Alessandro
BLOOD, 2007, 110 (11) : 170A - 171A
[5] The HDAC INHIBITOR ITF2357 MODULATES KEY HEMATOPOIETIC GENES in JAK2V617F CELLS From MYELOPROLIFERATIVE Neoplasm PATIENTS
Amaru, Ariel
Todoerti, Katia
Pellicioli, Anna
Donadoni, Luca
Tuana, Giacomo
Pedrini, Olga
Finazzi, Guido
Neri, Antonino
Fossati, Gianluca
Rambaldi, Alessandro
Introna, Martino
Lombardi, Luigia
Golay, Josee
BLOOD, 2010, 116 (21) : 348 - 349
[6] Potent inhibition of EEC colony formation in JAK2V617F PV and ET by low doses of ITF2357, a new histone deacetylase inhibitor.
Guerini, Vittoria
Spinelli, Orietta
Salvi, Anna
Finazzi, Guido
Barbui, Tiziano
Introna, Martino
Golay, Josee
Rambaldi, Alessandro
BLOOD, 2006, 108 (11) : 764A - 764A
[7] Potent and selective inhibition of EEC colony formation in JAK2V617F polycythemia vera and thrombocythemia by low doses of ITF2357, a new histone deacetylase inhibitor
Guerini, V.
Spinelli, O.
Salvi, A.
Finazzi, G.
Barbui, T.
Introna, M.
Golay, J.
Rambaldi, A.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 89 - 89
[8] Phase II study of the histone-deacetylase inhibitor ITF2357 in relapsed/refractory Hodgkin's lymphoma patients
Viviani, S.
Bonfante, V.
Fasola, C.
Valagussa, P.
Gianni, A. M.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[9] Potent and selective inhibition of EEC colony formation in JAK2V617F polycythemia vera and thrombocythemia by low doses of ITF2357, a new histone deacetylase inhibitor
Guerini, V
Spinelli, O.
Salvi, A.
Finazzi, G.
Barbui, T.
Introna, M.
Golay, J.
Rambaldi, A.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 123 - 123
[10] JAK2V617F allele burden in patients with myeloproliferative neoplasms
Salem H. Alshemmari
Reshmi Rajaan
Reem Ameen
Mohammad A. Al-Drees
Marwa R. Almosailleakh
Annals of Hematology, 2014, 93 : 791 - 796

← 1 2 3 4 5 →